Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 401 entries
View as:

Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00143533 Org: User:
Start: 09/30/03 End: 06/30/11 Due: 06/30/12

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

Phase: N/A Priority: Normal
NCT ID: NCT00244010 Org: User:
Start: 10/31/05 End: 02/28/09 Due: 02/28/10

Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05550948 Org: User:
Start: 01/05/23 End: 08/31/26 Due: 08/31/27

Human Immune Responses Toward HIV-1 Envelope Antigens

Phase: N/A Priority: Normal
NCT ID: NCT01344941 Org: User:
Start: 03/31/10 End: 11/30/15 Due: 11/30/16

Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05342155 Org: User:
Start: 03/20/23 End: 06/20/28 Due: 06/20/29

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02212561 Org: User:
Start: 08/31/14 End: 12/31/15 Due: 12/31/16

Working Memory Performance Among Childhood Brain Tumor Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00693914 Org: User:
Start: 04/30/07 End: 12/31/09 Due: 12/31/10

Natural Killer (NK) Cell Transplantation for AML

Phase: N/A Priority: Normal
NCT ID: NCT00187096 Org: User:
Start: 09/30/05 End: 03/31/13 Due: 03/31/14

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06177067 Org: User:
Start: 04/19/24 End: 07/31/26 Due: 07/31/27

Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission

Phase: N/A Priority: Normal
NCT ID: NCT00667927 Org: User:
Start: 03/31/91 End: 01/31/08 Due: 01/31/09

Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage

Phase: N/A Priority: Normal
NCT ID: NCT03194932 Org: User:
Start: 07/11/17 End: 06/22/22 Due: 06/22/23

Body Image in Youth With HIV

Phase: N/A Priority: Normal
NCT ID: NCT01673750 Org: User:
Start: 10/31/12 End: 12/31/13 Due: 12/31/14

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04923126 Org: User:
Start: 06/21/21 End: 06/30/31 Due: 06/30/32

Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program

Phase: N/A Priority: Normal
NCT ID: NCT01569971 Org: User:
Start: 03/31/12 End: 03/31/14 Due: 03/31/15

Learning Impairments Among Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00576472 Org: User:
Start: 01/31/00 End: 03/31/10 Due: 03/31/11

Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06747910 Org: User:
Start: 02/03/25 End: 02/28/26 Due: 02/28/27

Trial of Oral Glutamine in Patients With Sickle Cell Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00131508 Org: User:
Start: 05/31/04 End: 04/30/09 Due: 04/30/10

Large Cell Lymphoma Pilot Study III

Phase: N/A Priority: Normal
NCT ID: NCT00187070 Org: User:
Start: 12/31/97 End: 07/31/01 Due: 07/31/02

Social Emotional Development in Young Children With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03086421 Org: User:
Start: 07/11/17 End: 06/30/28 Due: 06/30/29

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

Phase: N/A Priority: Normal
NCT ID: NCT06442761 Org: User:
Start: 11/14/24 End: 07/31/26 Due: 07/31/27

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

Phase: N/A Priority: Normal
NCT ID: NCT02125786 Org: User:
Start: 05/07/14 End: 05/31/28 Due: 05/31/29

Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT00187018 Org: User:
Start: 03/31/04 End: 08/31/07 Due: 08/31/08

Antibiotic Resistance in Global Pediatric Oncology Centers

Phase: N/A Priority: Normal
NCT ID: NCT03721562 Org: User:
Start: 02/26/19 End: 07/29/22 Due: 07/29/23

Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02336282 Org: User:
Start: 01/12/15 End: 07/20/17 Due: 07/20/18

Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT01959958 Org: User:
Start: 10/31/13 End: 04/30/16 Due: 04/30/17